An Accurate and Effective Method for Measuring Osimertinib by UPLC-TOF-MS and Its Pharmacokinetic Study in Rats

Song-Tao Dong1,2, Ying Li3, Hao-Tian Yang4

  • 1National Clinical Drug Monitoring Center, Department of Pharmacy, Hebei Province General Center, Shijiazhuang 050051, China. dongsongtao8886@163.com.

Insights

A new method quantifies osimertinib in rat plasma using ultra-performance liquid chromatography-time of flight mass spectrometry (UPLC-TOF-MS). This validated technique accurately measures osimertinib, aiding pharmacokinetic studies.

Area of Science:

  • Analytical Chemistry
  • Pharmacology
  • Biochemistry

Background:

  • Osimertinib is a key treatment for advanced epidermal growth factor receptor (EGFR) T790M mutation-positive tumors.
  • Accurate quantification of osimertinib is crucial for understanding its behavior in vivo.
  • Existing analytical methods may require enhancement for specific applications like pharmacokinetic studies.

Purpose of the Study:

  • To develop and validate an original analytical method for quantifying osimertinib in rat plasma.
  • To assess the method's specificity, accuracy, and precision.
  • To apply the validated method to pharmacokinetic studies in Sprague-Dawley (SD) rats.

Main Methods:

  • Ultra-performance liquid chromatography with time of flight mass spectrometry (UPLC-TOF-MS) was employed.
  • Acetonitrile was used for protein precipitation, with sorafinib as the internal standard.
  • Chromatography was performed on a Waters XTerra MS C18 column using a mobile phase of acetonitrile and water with 0.1% ammonia.

Main Results:

  • The developed UPLC-TOF-MS method demonstrated high specificity, accuracy, and precision.
  • Intra-day and inter-day relative standard deviations (RSD) were within acceptable ranges (5.38–9.76% and 6.02–9.46%, respectively).
  • Extraction recovery (84.31–96.14%) and matrix effects (91.46–97.18%) were within acceptable limits.

Conclusions:

  • A robust and validated UPLC-TOF-MS method for osimertinib quantification in rat plasma was successfully established.
  • The method's performance characteristics confirm its suitability for analytical purposes.
  • The validated method was effectively utilized in the pharmacokinetic analysis of osimertinib in SD rats.

Related Concept Videos

Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
289
Effects of EDTA on End-Point Detection Methods01:18

Effects of EDTA on End-Point Detection Methods

Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
664
MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
6.8K
Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.9K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
539
Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.5K